Source:http://linkedlifedata.com/resource/pubmed/id/15517712
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
41
|
pubmed:dateCreated |
2004-11-2
|
pubmed:language |
swe
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0023-7205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3160-1
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15517712-Anemia,
pubmed-meshheading:15517712-Erythropoietin,
pubmed-meshheading:15517712-Humans,
pubmed-meshheading:15517712-Otorhinolaryngologic Neoplasms,
pubmed-meshheading:15517712-Practice Guidelines as Topic,
pubmed-meshheading:15517712-Prognosis,
pubmed-meshheading:15517712-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
[Erythropoietin can reduce the effect of radiotherapy].
|
pubmed:affiliation |
Onkologikliniken, Gävle sjukhus. stefan.bergstrom@lg.se
|
pubmed:publicationType |
Journal Article
|